logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kamel Laribi

ch le mans
H指数:33
被引数:5,071

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal assessments of MRD in high-risk newly diagnosed transplant-ineligible multiple myeloma in the BENEFIT study (IFM2020-05)

BENEFIT研究（IFM2020-05）中高危初诊非移植候选多发性骨髓瘤的MRD纵向评估

HemaSphere
IF14.6
2026-10-050
OAAI
Jill Corre; Jerome Lambert; Arthur Bobin; Salomon Manier; Aurore Perrot; Lionel Karlin; Murielle Roussel; Noemie Bigot; Omar Benbrahim; Olivier Allangba; Philippe Rey; Véronique Dorvaux; Marguerite Vignon; Virginie Roland; Réda Garidi; Jean-Noel Bastie; Marie-Lorraine Chretien; Sophie Godet; Lydia Montes; Brieuc Cherel; Anne Vekhoff; Thomas Chalopin; Borhane Slama; Kamel Laribi; Claire Dingremont; Christophe Roul; Valentine Richez-Olivier; Clara Mariette; Sophie Rigaudeau; Claire Calmettes; Mamoun Dib; Mourad Tiab; Laure Vincent; Jacques Delaunay; Sabrina Maheo; Anais Schavgoulidze; Laurent Frenzel; Pascal Godmer; Ronan Le Calloch; Emilie Chalayer; Helene Gardeney; Margaret Macro; Bruno Royer; Stephanie Harel; Olivier Decaux; Bertrand Arnulf; Karim Belhadj; Aurelie Gontier; Cyrille Touzeau; Mohamad Mohty; Philippe Moreau; Thierry Facon; Cyrille Hulin; Xavier Leleu
Relapsed/refractory WAldenström macroglobulinemia patients treated by VEnetoclax with or without anti-CD20 antibody: WAVE a retrospective study of the French CLL/WM group (FILO)

复发/难治性华氏巨球蛋白血症患者采用维奈克拉单抗联合或不联合抗CD20抗体治疗的WAVE研究：法国CLL/WM组（FILO）的回顾性研究

Annals of Hematology
IF2.4
2026-10-020
OAAI
Mathilde Vonfeld; Thomas Systchenko; Pierre-Edouard Debureaux; Jehan Dupuis; Damien Roos-Weil; Loïc Ysebaert; Marie-Sarah Dilhuydy; Marion Malphettes; Carolyne Croizier; Thérèse Aurran; Luca Inchiappa; Lise Willems; Benedicte Hivert; Vincent Lévy; Lucille Bussot; Florian Bouclet; Kamel Laribi; Aline Clavert; Amandine Durand; Cécile Tomowiak
Allele burden expansion in JAK2V617F and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment

JAK2<sup>V617F</sup>和CALR突变骨髓增殖性肿瘤中的等位基因负荷扩增预测疾病进展并与安归那治疗相关

HemaSphere
IF14.6
2026-09-010
OAAI
Zi Yun Ng; Laurane Cottin; Marine Demoy; Damien Luque Paz; Corentin Orvain; Wayne-Corentin Lambert; Jean-Christophe Ianotto; Eric Lippert; David M. Ross; Diana Iarossi; Alesia Khan; Daniel Lock; Catherine Truong; Kamel Laribi; Yun Fan Yang; Laura Li Gagnon; Valerie Ugo; Claire N. Harrison; Jennifer O'Sullivan
Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study

影响慢性淋巴细胞白血病一线治疗的因素：一项法国真实世界研究

Cancer
IF5.1
2026-04-150
OAAI
Arthur Coste MScEng, PhD, MD; Nanthara Sritharan MSc; Anne Lok MD; Cécile Tomowiak MD; Emmanuelle Ferrant MD; Aline Clavert MD; Damien Roos-Weil MD, PhD; Florian Bouclet MD; Adrien Caillet MD; Carolyne Croizier MD, PhD; Nicolas Stocker MD, PhD; Emmanuelle Tchernonog MD; Pierre Feugier MD, PhD; Alberto Santagostino MD; Bénédicte Hivert MD; Anne-Sophie Michallet MD, PhD; Sophie De Guibert MD; Diane Lara MD; Agathe Waultier-Rascalou MD; Fatiha Merabet MD; Amandine Durand MD; Lucile Bussot MD; Kamel Laribi MD; Marie-sarah Dilhuydy MD; Vincent Lévy MD, PhD; Anne Quinquenel MD, PhD
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia

Waldenström巨球蛋白血症患者一线苯达莫司汀联合利妥昔单抗方案的晚期毒性和长期疗效

Leukemia
IF13.4
2025-12-090
PRE
Véronique Leblond; Jean-Richard Eveillard; Driss Chaoui; Doriane Cavalieri; Caroline Dartigeas; Lise Willems; Ronan Le Calloch; Fathia Merabet; Xavier Roussel; Benoît Bareau; Sabine Tricot; Jehan Dupuis; Stéphanie Poulain; Kamel Laribi; Damien Roos-Weil
Waldenström’s macroglobulinemia: the LYSA pragmatic guidelines

华氏巨球蛋白血症：LYSA实用指南

European Journal of Cancer
IF7.1
2025-11-280
PRE
Damien Roos-Weil; Cécile Tomowiak; Stéphanie Poulain; Florence Nguyen-Khac; Florian Bouclet; Marine Armand; Thérèse Aurran; Eric Durot; David Ghez; Bénédicte Hivert; Kamel Laribi; Magali Le Garff Tavernier; Stéphane Lepretre; Lydia Montes; Amine Moslemi; Laurence Simon; Véronique Leblond; Pierre Morel; Olivier Tournilhac
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

低剂量阿糖胞苷和维奈克拉在不符合强化疗条件的急性髓系白血病患者中的风险分层

Blood Advances
IF7.1
2025-11-240
OAAI
Andrew H. Wei; Panayiotis Panayiotidis; Pau Montesinos; Kamel Laribi; Vladimir Ivanov; Inho Kim; Jan Novak; Rebecca Champion; Walter Fiedler; Maria Pagoni; Julie Bergeron; Stephen B. Ting; Jing-Zhou Hou; Takahiro Yamauchi; Jianxiang Wang; Stephen A. Strickland; Michael R. Savona; Tara L. Lin; Anoop Enjeti; Ing Soo Tiong
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

分歧的分子通路驱动单形态上皮亲嗜性及肠病相关肠道T细胞淋巴瘤

Leukemia
IF13.4
2025-10-070
OA
David Vallois; Edoardo Missiaglia; Luis Veloza; Anja Fischer; Doriane Cavalieri; Vimel Rattina; Bettina Bisig; Vincent Roh; Laura Wiehle; Rita Sarkis; Emmanuel Bachy; Christophe Bonnet; Julie Bruneau; Anne Cairoli; Roland De Wind; Fanny Drieux; Romain Dubois; Jean-François Emile; Virginie Fataccioli; Kamel Laribi; Albane Ledoux-Pilon; François Lemonnier; Francisco Llamas-Gutierrez; Pierre Morel; Marie Parrens; Elsa Poullot; Leticia Quintanilla-Martinez; Jeremy Sandrini; Joan Somja; Luc Xerri; Olivier Tournilhac; Philippe Gaulard; Reiner Siebert; Laurence de Leval
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial

脆弱及新诊断多发性骨髓瘤患者中地塞米松减量方案联合达拉珠单抗和来那度胺的安全性与有效性（IFM2017-03）：一项III期、开放标签、多中心、随机对照试验

The Lancet Oncology
IF0
2025-09-290
OAAI
Salomon Manier; Jérôme Lambert; Cyrille Hulin; Margaret Macro; Kamel Laribi; Carla Araujo; Gian Matteo Pica; Cyrille Touzeau; Pascal Godmer; Borhane Slama; Lionel Karlin; Frédéric Orsini Piocelle; Mamoun Dib; Laurence Sanhes; Pierre Morel; Abderazzak El Yamani; Mourad Tiab; Reza Tabrizi; Valentine Richez; Laurent Garderet; Bruno Royer; Benoit Bareau; Clara Mariette; Emmanuel Fleck; Daniela Robu; Claire Calmettes; Sophie Rigaudeau; Hélène Demarquette; Laurent Frenzel; Olivier Decaux; Mohamad Mohty; Bertrand Arnulf; Noémie Bigot; Aurore Perrot; Jill Corre; Jean-Yves Mary; Hervé Avet-Loiseau; Philippe Moreau; Xavier Leleu; Thierry Facon
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

zanubrutinib在del(17p)和/或TP53 CLL/SLL患者治疗中的应用：临床研究分析

Blood Advances
IF7.1
2025-08-220
OAAI
Constantine S. Tam; Mary Ann Anderson; Martin Šimkovič; Paolo Ghia; Ian W. Flinn; Kamel Laribi; Stephen Opat; Gavin Cull; Talha Munir; Anders Österborg; Alessandra Tedeschi; Megan Wang; Andy Szeto; Heather Allewelt; Tommi Salmi; Jessica Li; Linlin Xu; Ken Wu; Remus Vezan; Mazyar Shadman; Jennifer R. Brown
The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study

抗CD38单克隆抗体在初诊多发性骨髓瘤患者一线治疗中的影响：来自EMMY研究的真实世界结果

clinical lymphoma myeloma leukemia
IF0
2025-07-240
PRE
Thomas Chalopin; Olivier Decaux; Cyrille Hulin; Aurore Perrot; Margaret Macro; Bruno Royer; Jean-Noel Bastie; Arthur Bobin; Caroline Jacquet; Mohamad Mohty; Laurent Frenzel; Cécile Sonntag; Murielle Roussel; Laurence Sanhes; Driss Chaoui; Mamoun Dib; Borhane Slama; Valentine Richez; Lydia Montes; Isabelle Dervite; Kamel Laribi; Daniel Re; Ronan Garlantezec; Karim Belhadj Merzoug; Laure Vincent
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma

身体成分对原发性纵隔大B细胞淋巴瘤患者治疗毒性和预后的影响

Hematological Oncology
IF3.9
2025-07-110
OAAI
Juliette Penichoux; Pierre Decazes; Cédric Rossi; Pierre Sesques; Corinne Haioun; Eric Durot; Nicolas Gower; Alexandre Willaume; Lucie Oberic; Jérome Paillassa; Chloé Antier; Loic Renaud; Olivier Tournilhac; Catherine Thieblemont; Caroline Besson; Laure Lebras; Sylvain Choquet; Katell Le Du; Christophe Bonnet; Sarah Bailly; Ghandi Damaj; Kamel Laribi; Roch Houot; Adrien Chauchet; Stéphanie Becker; David Tonnelet; Hervé Tilly; Fabrice Jardin; Emilie Lévêque; Vincent Camus
A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

一项评估低剂量去铁酮在经促红细胞生成素刺激剂治疗后耐药或复发的低风险骨髓增生异常综合征患者中的前瞻性研究（LODEFI）

BLOOD
IF23.1
2024-11-050
PRE
Meunier, Mathieu; Thepot, Sylvain; Nimubona, Stanislas; Veloso, Melanie; Lefebvre, Thibaud; Zoubida, Karim; Ropert-Bouchet, Martine; Garban, Frederic; Ame, Shanti; Gandoul, Abdesssamia; Reynes, Claire; Salanoubat, Celia; Maury, Sebastien; Laribi, Kamel; Eftekhari, Pirayeh; Delaunay, Jacques; Venton, Geoffroy; Santana, Clemence; Cheze, Stephane; Dimicoli-Salazar, Sophie; Molimard, Mathieu; Rolland-Neyret, Valerie; David-Tchouda, Sandra; Park, Sophie
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

HEMASPHERE
IF14.6
2024-09-170
OAAI
Chatzikonstantinou, Thomas; Scarfo, Lydia; Minga, Eva; Karakatsoulis, Georgios; Chamou, Dimitra; Kotaskova, Jana; Iacoboni, Gloria; Demosthenous, Christos; Albi, Elisa; Alcoceba, Miguel; Al-Shemari, Salem; Aurran-Schleinitz, Therese; Bacchiarri, Francesca; Chatzileontiadou, Sofia; Collado, Rosa; Davis, Zadie; de Deus Santos, Marcos Daniel; Dimou, Maria; Dmitrieva, Elena; Donaldson, David; Dos Santos, Gimena; Dreta, Barbara; Efstathopoulou, Maria; El-Ashwah, Shaimaa; Enrico, Alicia; Frygier, Andrzej; Galimberti, Sara; Galitzia, Andrea; Gimeno, Eva; Guarente, Valerio; Guieze, Romain; Harrop, Sean; Hatzimichael, Eleftheria; Herishanu, Yair; Hernandez-Rivas, Jose-angel; Jaksic, Ozren; Kalicinska, Elzbieta; Laribi, Kamel; Karakus, Volkan; Kater, Arnon P.; Kho, Bonnie; Kislova, Maria; Konstantinou, Eliana; Koren-Michowitz, Maya; Kotsianidis, Ioannis; Kubova, Zuzana; Labrador, Jorge; Lad, Deepesh; Laurenti, Luca; Longval, Thomas; Lopez-Garcia, Alberto; Marquet, Juan; Maslejova, Stanislava; Mayor-Bastida, Carlota; Mihaljevic, Biljana; Milosevic, Ivana; Miras, Fatima; Moia, Riccardo; Morawska, Marta; Nath, Uttam K.; Navarro-Bailon, Almudena; Olivieri, Jacopo; Panovska-Stavridis, Irina; Papaioannou, Maria; Pierie, Cheyenne; Puiggros, Anna; Reda, Gianluigi; Rigolin, Gian M.; Ruchlemer, Rosa; Schipani, Mattia; Schiwitza, Annett; Shen, Yandong; Shokralla, Tereza; Simkovic, Martin; Smirnova, Svetlana; Soliman, Dina S. A.; Stilgenbauer, Stephan; Tadmor, Tamar; Tomic, Kristina; Tse, Eric; Vassilakopoulos, Theodoros; Visentin, Andrea; Vitale, Candida; Vrachiolias, George; Vukovic, Vojin; Walewska, Renata; Xu, Zhenshu; Yagci, Munci; Yanez, Lucrecia; Yassin, Mohamed; Zuchnicka, Jana; Oscier, David; Gozzetti, Alessandro; Panagiotidis, Panagiotis; Bosch, Francesc; Sportoletti, Paolo; Espinet, Blanca; Pangalis, Gerassimos A.; Popov, Viola M.; Mulligan, Stephen; Angelopoulou, Maria; Demirkan, Fatih; Papajik, Tomas; Biderman, Bella; Murru, Roberta; Coscia, Marta; Tam, Constantine; Cuneo, Antonio; Gaidano, Gianluca; Claus, Rainer; Stavroyianni, Niki; Trentin, Livio; Antic, Darko; Smolej, Lukas; Kalashnikova, Olga B.; Catherwood, Mark; Spacek, Martin; Pospisilova, Sarka; Doubek, Michael; Nikitin, Eugene; Chatzidimitriou, Anastasia; Ghia, Paolo; Stamatopoulos, Kostas
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
NATURE MEDICINE
IF50
2024-06-038
OAAI
Leleu, Xavier; Hulin, Cyrille; Lambert, Jerome; Bobin, Arthur; Perrot, Aurore; Karlin, Lionel; Roussel, Murielle; Montes, Lydia; Cherel, Brieuc; Chalopin, Thomas; Slama, Borhane; Chretien, Marie-Lorraine; Laribi, Kamel; Dingremont, Claire; Roul, Christophe; Mariette, Clara; Rigaudeau, Sophie; Calmettes, Claire; Dib, Mamoun; Tiab, Mourad; Vincent, Laure; Delaunay, Jacques; Santagostino, Alberto; Macro, Margaret; Bourgeois, Emmanuelle; Orsini-Piocelle, Frederique; Gay, Julie; Bareau, Benoit; Bigot, Noemie; Vergez, Francois; Lebreton, Pierre; Tabrizi, Reza; Waultier-Rascalou, Agathe; Frenzel, Laurent; Le Calloch, Ronan; Chalayer, Emilie; Braun, Thorsten; Lachenal, Florence; Corm, Selim; Kennel, Celine; Belkhir, Rakiba; Blade, Jean-Sebastien; Joly, Bertrand; Richez-Olivier, Valentine; Gardeney, Helene; Demarquette, Helene; Robu-Cretu, Daniela; Garderet, Laurent; Newinger-Porte, Muriel; Kasmi, Amine; Royer, Bruno; Decaux, Olivier; Arnulf, Bertrand; Belhadj, Karim; Touzeau, Cyrille; Mohty, Mohamad; Manier, Salomon; Moreau, Philippe; Avet-Loiseau, Herve; Corre, Jill; Facon, Thierry
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease

慢性粒单核细胞白血病患者溶菌酶肾病和肾浸润显示严重疾病的标志物

KIDNEY INTERNATIONAL REPORTS
IF5.7
2023-12-011
OAAI
Lafargue, Marie-Camille; Bobot, Mickael; Rennke, Helmut G.; Essig, Marie; Carre, Martin; Mercadal, Lucile; Farhi, Jonathan; Sakhi, Hamza; Comont, Thibault; Golbin, Leonard; Isnard, Pierre; Chemouny, Jonathan; Cambier, Nathalie; Laribi, Kamel; Selamet, Umut; V. Riella, Leonardo; Fain, Olivier; Ades, Lionel; Fenaux, Pierre; Cohen, Camille; Mekinian, Arsene
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study

ixazomib联合来那度胺和地塞米松在复发/难治性多发性骨髓瘤中的真实疗效: REMIX研究

ANNALS OF HEMATOLOGY
IF2.4
2023-06-105
OAAI
Macro, M.; Hulin, C.; Vincent, L.; Charvet-Rumpler, A.; Benboubker, L.; Calmettes, C.; Stoppa, A. -m.; Laribi, K.; Clement-Filliatre, L.; Zerazhi, H.; Honeyman, F.; Richez, V.; Maloisel, F.; Karlin, L.; Barrak, J.; Chouaid, C.; Leleu, X.
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
HAEMATOLOGICA
IF7.9
2023-04-209
OAAI
Talbot, Alexis; Bobin, Arthur; Tabone, Lea; Lambert, Jerome; Boccaccio, Catherine; Deal, Cecile; Petillon, Marie-Odile; Allangba, Olivier; Agape, Philippe; Arnautou, Pierre; Belkhir, Rakiba; Cailleres, Sylvie; Chaoui, Driss; Chretien, Marie-Lorraine; Decaux, Olivier; Schulmann, Samantha; Frenzel, Laurent; Gastaud, Lauris; Huart, Antoine; Hulin, Cyrille; Karlin, Lionel; Laribi, Kamel; Le Calloch, Ronan; Lenain, Pascal; Macro, Margaret; Manier, Salomon; Montes, Lydia; Moreau, Stephane; Moreau, Philippe; Morel, Veronique; Norwood, James; Piocelle, Frederique Orsini; Perrot, Aurore; Pica, Gian Matteo; Rey, Philippe; Schmitt, Anna; Stoppa, Anne-Marie; Tiab, Mourad; Touzeau, Cyrille; Vidal, Valerie; Vignon, Marguerite; Vincent, Laure; Van De Wyngaert, Zoe; Zarnitsky, Charles; Kerbouche, Naima; Paka, Prani; Leleu, Xavier; Arnulf, Bertrand; Avet-Loiseau, Herve
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO
LEUKEMIA
IF13.4
2022-09-073
OAAI
Kubasch, Anne Sophie; Giagounidis, Aristoteles; Metzgeroth, Georgia; Jonasova, Anna; Herbst, Regina; Diaz, Jose Miguel Torregrosa; De Renzis, Benoit; Gotze, Katharina S.; Huetter-Kroenke, Marie-Luise; Gourin, Marie-Pierre; Slama, Borhane; Dimicoli-Salazar, Sophie; Cony-Makhoul, Pascale; Laribi, Kamel; Park, Sophie; Jersemann, Katja; Schipp, Dorothea; Metzeler, Klaus H.; Tiebel, Oliver; Sockel, Katja; Gloaguen, Silke; Mies, Anna; Chermat, Fatiha; Thiede, Christian; Sapena, Rosa; Schlenk, Richard F.; Fenaux, Pierre; Platzbecker, Uwe; Ades, Lionel
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
BLOOD ADVANCES
IF7.1
2022-09-0620
OAAI
Sobas, Marta; Kiladjian, Jean-Jacques; Beauverd, Yan; Curto-Garcia, Natalia; Sadjadian, Parvis; Shih, Lee Yung; Devos, Timothy; Krochmalczyk, Dorota; Galli, Serena; Bieniaszewska, Maria; Seferynska, Ilona; McMullin, Mary Frances; Armatys, Anna; Spalek, Adrianna; Waclaw, Joanna; Zdrenghea, Mihnea; Legros, Laurence; Girodon, Francois; Lewandowski, Krzysztof; Figueras, Anna Angona; Samuelsson, Jan; Blanco, Aitor Abuin; Cony-Makhoul, Pascale; Collins, Angela; James, Chloe; Kusec, Rajko; Lauermannova, Marie; Noya, Maria Sol; Skowronek, Malgorzata; Szukalski, Lukasz; Szmigielska-Kaplon, Anna; Wondergem, Marielle; Dudchenko, Iryna; Tybor, Joanna Gora; Laribi, Kamel; de Nalecz, Anna Kulikowska; Demory, Jean-Loup; Le Du, Katell; Zweegman, Sonja; Raebel, Carlos Besses; Skoda, Radek; Giraudier, Stephane; Griesshammer, Martin; Harrison, Claire N.; Ianotto, Jean-Christophe

研究方向

暂未获取到该数据
R
Ronan Le Calloch
H 指数:14论文数:70被引数:973
E
Emmanuel Gyan
H 指数:55论文数:422被引数:1.0万
A
Alix Baugier de Materre
H 指数:10论文数:25被引数:445
L
Laure Vincent
H 指数:27论文数:206被引数:3,180
X
Xavier Leleu
H 指数:93论文数:1,209被引数:4.2万
C
Cyrille Hulin
H 指数:45论文数:317被引数:1.3万
A
Aurore Perrot
H 指数:43论文数:452被引数:1.1万
L
Lydia Montes
H 指数:11论文数:308被引数:414
L
Laurent Frenzel
H 指数:27论文数:216被引数:5,265
P
Pierre Morel
H 指数:52论文数:225被引数:2.1万